NEW YORK (360Dx) – Intuity Medical announced today that it has raised an additional $15 million in Series 3 financing, bringing the total value of the round to $55 million.
New investors in the round include KCK Group, PTV Healthcare Capital, and affiliates of Luther King Capital Management. Existing investors in the privately held company include Accuitive Medical Ventures, Investor Growth Capital, US Venture Partners, Venrock, and Versant Ventures.
Intuity Medical President and CEO Emory Anderson said that the additional funding will help the company further its efforts to commercialize its Pogo Automatic blood glucose monitoring system, which was approved by the US Food and Drug Administration in April 2016.
According to the company, the Pogo Automatic is the first blood glucose meter and multi-test cartridge to provide automatic testing with lancing, blood collection, and analysis in a single step without the need for separate strips and lancets.